Riskpilot← Back to searchSign inGet full accessDermadicare AB
ABActiveOrg 5567729651Solna Torg 19Other financial service activities, except insurance and pension funding n.e.c. · NACE 6499Est. 20085-9 employees
Revenue 2024
SEK 8,4M
+10% vs 2023
EBITDA margin
21.7%
+107% vs 2023
Equity ratio
25.5%
Financial strength
Net profit 2024
SEK 909K
+298% vs 2023
| Revenue | SEK 8,4M | +10% |
| EBITDA | SEK 1,8M | +107% |
| Net profit | SEK 909K | +298% |
| Total assets | SEK 16,5M | +4% |
| Equity | SEK 4,2M | +28% |
| Employees | — | — |
Legal name
Dermadicare AB
Org number
5567729651
Legal form
Aktiebolag
NACE code
6499 · Other financial service activities, except insurance and pension funding n.e.c.
Founded
15 december 2008
Share capital
SEK 100 000
Employees
5-9
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolagets ska bedriva läkarverksamhet inom estetisk kirurgi, skönhets- och hudvård, handel med värdepapper, vidare import och export av hudvårdsprodukter samt därmed förenlig verksamhet.
Address
Solna Torg 19
Email
jean@lasercenter.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 11 211 | 71 790 | 61 309 | 166 991 | 8 674 | 8 103 | 7 649 | 8 389 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | 3 765 | 6 534 | 3 192 | −2 667 | 4 456 | −3 645 | 1 987 | 1 031 | 878 | 1 818 |
| Depreciation & amort. | −526 | −283 | −445 | −403 | −255 | −222 | −224 | −85 | −195 | −203 |
| EBIT | 3 239 | 6 251 | 2 747 | −3 070 | 4 201 | −3 867 | 1 763 | 946 | 683 | 1 615 |
| Net financials | −6 | 5 287 | 1 783 | −23 | −1 503 | −1 509 | −2 129 | −2 931 | −1 884 | −1 004 |
| Profit before tax | 2 575 | 8 931 | 3 596 | 3 721 | 2 393 | −3 568 | 672 | −587 | −458 | 1 148 |
| Tax | −600 | −1 971 | −802 | −34 | −677 | −0 | −0 | −0 | −0 | −239 |
| Net profit | 1 975 | 6 960 | 2 794 | 3 687 | 1 716 | −3 568 | 672 | −587 | −458 | 909 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 10 566 | 23 041 | 22 496 | 12 796 | 11 939 | 7 390 | 8 224 | 14 470 | 15 828 | 16 453 |
| Equity | 5 701 | 11 661 | 11 455 | 9 518 | 7 234 | 3 666 | 4 338 | 3 752 | 3 293 | 4 202 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7 000 | 8 342 | 8 758 |
| Short-term debt | 1 592 | 5 500 | 4 227 | 3 278 | 3 650 | 3 724 | 3 886 | 3 718 | 4 193 | 3 492 |
| Total debt | 1 592 | 5 500 | 4 227 | 3 278 | 3 650 | 3 724 | 3 886 | 10 718 | 12 535 | 12 250 |
EBITDA margin
21.7%
This company
15.8%
Market median
+37% vs market
20152024
Equity ratio
25.5%
This company
38.2%
Market median
-33% vs market
20152024
Return on equity
21.6%
This company
18.4%
Market median
+17% vs market
20152024
Net profit margin
10.8%
This company
8.1%
Market median
+33% vs market
20152024
Asset turnover
0.51×
This company
1.12×
Market median
-54% vs market
20152024
Debt / equity
2.92×
This company
0.62×
Market median
-371% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
SM | Audit | 2022 | — | — |
JG Chief Executive Officer | Chief Executive Officer | 2024 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Prime Clinics Sweden AB | Company | 100.0% | 100.0% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Prime Clinics Sweden AB
Dermadicare AB Board members of Dermadicare AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Stig Michael Johansson | Audit | 0 companies |
| Jean George Hadad | Chief Executive Officer | 0 companies |
| Jozef Hadad | Deputy Board Member | 0 companies |